

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 6.20002356 |
| 2 | central nervous system myelination (GO:0022010) | 6.20002356 |
| 3 | fatty acid elongation (GO:0030497) | 5.46916619 |
| 4 | platelet dense granule organization (GO:0060155) | 5.07963184 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.67525028 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 4.67525028 |
| 7 | presynaptic membrane assembly (GO:0097105) | 4.29428220 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 4.23352147 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.95826428 |
| 10 | L-phenylalanine metabolic process (GO:0006558) | 3.95826428 |
| 11 | bile acid biosynthetic process (GO:0006699) | 3.87482793 |
| 12 | DNA deamination (GO:0045006) | 3.82900778 |
| 13 | L-fucose catabolic process (GO:0042355) | 3.81224608 |
| 14 | fucose catabolic process (GO:0019317) | 3.81224608 |
| 15 | L-fucose metabolic process (GO:0042354) | 3.81224608 |
| 16 | tryptophan catabolic process (GO:0006569) | 3.80617393 |
| 17 | indole-containing compound catabolic process (GO:0042436) | 3.80617393 |
| 18 | indolalkylamine catabolic process (GO:0046218) | 3.80617393 |
| 19 | presynaptic membrane organization (GO:0097090) | 3.80491333 |
| 20 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 3.69942910 |
| 21 | cholesterol biosynthetic process (GO:0006695) | 3.65054210 |
| 22 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.61446459 |
| 23 | myelination (GO:0042552) | 3.59845585 |
| 24 | very long-chain fatty acid metabolic process (GO:0000038) | 3.51649337 |
| 25 | axon ensheathment (GO:0008366) | 3.50062616 |
| 26 | ensheathment of neurons (GO:0007272) | 3.50062616 |
| 27 | tryptophan metabolic process (GO:0006568) | 3.45759290 |
| 28 | cellular biogenic amine catabolic process (GO:0042402) | 3.44150823 |
| 29 | amine catabolic process (GO:0009310) | 3.44150823 |
| 30 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.38132931 |
| 31 | glyoxylate metabolic process (GO:0046487) | 3.37881753 |
| 32 | opsonization (GO:0008228) | 3.37633945 |
| 33 | glycerophospholipid catabolic process (GO:0046475) | 3.36553753 |
| 34 | eye photoreceptor cell differentiation (GO:0001754) | 3.36439058 |
| 35 | photoreceptor cell differentiation (GO:0046530) | 3.36439058 |
| 36 | anterograde synaptic vesicle transport (GO:0048490) | 3.36163194 |
| 37 | omega-hydroxylase P450 pathway (GO:0097267) | 3.28082968 |
| 38 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.26612626 |
| 39 | protein neddylation (GO:0045116) | 3.26385973 |
| 40 | neuron cell-cell adhesion (GO:0007158) | 3.24675290 |
| 41 | limb bud formation (GO:0060174) | 3.21560898 |
| 42 | transmission of nerve impulse (GO:0019226) | 3.19979752 |
| 43 | neural tube formation (GO:0001841) | 3.17397643 |
| 44 | nucleotide transmembrane transport (GO:1901679) | 3.16112900 |
| 45 | regulation of collateral sprouting (GO:0048670) | 3.15122449 |
| 46 | DNA double-strand break processing (GO:0000729) | 3.13800910 |
| 47 | piRNA metabolic process (GO:0034587) | 3.11198693 |
| 48 | import into cell (GO:0098657) | 3.09568549 |
| 49 | regulation of fibrinolysis (GO:0051917) | 3.08193316 |
| 50 | oligodendrocyte differentiation (GO:0048709) | 3.06584445 |
| 51 | sterol biosynthetic process (GO:0016126) | 3.06203586 |
| 52 | kynurenine metabolic process (GO:0070189) | 3.05953032 |
| 53 | bile acid metabolic process (GO:0008206) | 3.03009350 |
| 54 | short-term memory (GO:0007614) | 2.97456508 |
| 55 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.97136212 |
| 56 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.94669727 |
| 57 | cullin deneddylation (GO:0010388) | 2.94250456 |
| 58 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.94153637 |
| 59 | L-amino acid import (GO:0043092) | 2.94079550 |
| 60 | response to xenobiotic stimulus (GO:0009410) | 2.90330439 |
| 61 | aromatic amino acid family metabolic process (GO:0009072) | 2.87714861 |
| 62 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.87065652 |
| 63 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.86948946 |
| 64 | axoneme assembly (GO:0035082) | 2.86678423 |
| 65 | response to methylmercury (GO:0051597) | 2.86313746 |
| 66 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.84587604 |
| 67 | behavioral response to nicotine (GO:0035095) | 2.83807468 |
| 68 | NAD biosynthetic process (GO:0009435) | 2.83549951 |
| 69 | isoprenoid biosynthetic process (GO:0008299) | 2.81073511 |
| 70 | indolalkylamine metabolic process (GO:0006586) | 2.80831402 |
| 71 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.77070286 |
| 72 | protein localization to cilium (GO:0061512) | 2.76511745 |
| 73 | protein deneddylation (GO:0000338) | 2.75231634 |
| 74 | respiratory chain complex IV assembly (GO:0008535) | 2.74636873 |
| 75 | protein-cofactor linkage (GO:0018065) | 2.73964168 |
| 76 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.73947635 |
| 77 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.73947635 |
| 78 | cell wall macromolecule catabolic process (GO:0016998) | 2.73179517 |
| 79 | complement activation, alternative pathway (GO:0006957) | 2.73089461 |
| 80 | proteasome assembly (GO:0043248) | 2.72229997 |
| 81 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.72048174 |
| 82 | protein carboxylation (GO:0018214) | 2.71728412 |
| 83 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.71728412 |
| 84 | coenzyme catabolic process (GO:0009109) | 2.65362261 |
| 85 | regulation of cilium movement (GO:0003352) | 2.65359700 |
| 86 | organelle disassembly (GO:1903008) | 2.64627082 |
| 87 | regulation of cholesterol esterification (GO:0010872) | 2.64560705 |
| 88 | negative regulation of lipase activity (GO:0060192) | 2.64078871 |
| 89 | positive regulation of defense response to virus by host (GO:0002230) | 2.64050908 |
| 90 | regulation of protein activation cascade (GO:2000257) | 2.63834743 |
| 91 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.63793713 |
| 92 | nucleotide transport (GO:0006862) | 2.62417358 |
| 93 | retina layer formation (GO:0010842) | 2.61910398 |
| 94 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.61673928 |
| 95 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.60933230 |
| 96 | high-density lipoprotein particle remodeling (GO:0034375) | 2.60335353 |
| 97 | tyrosine metabolic process (GO:0006570) | 2.60000345 |
| 98 | positive regulation of protein kinase C signaling (GO:0090037) | 2.59640112 |
| 99 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.59309528 |
| 100 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.58648378 |
| 101 | negative regulation of telomere maintenance (GO:0032205) | 2.57198005 |
| 102 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.56668538 |
| 103 | blood coagulation, intrinsic pathway (GO:0007597) | 2.55873999 |
| 104 | response to redox state (GO:0051775) | 2.55519820 |
| 105 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.54476352 |
| 106 | ubiquinone biosynthetic process (GO:0006744) | 2.54139856 |
| 107 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.54052843 |
| 108 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.54052843 |
| 109 | peroxisome fission (GO:0016559) | 2.53788669 |
| 110 | protein complex biogenesis (GO:0070271) | 2.53683465 |
| 111 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.53162946 |
| 112 | response to interferon-beta (GO:0035456) | 2.53160089 |
| 113 | cilium morphogenesis (GO:0060271) | 2.52897777 |
| 114 | mannosylation (GO:0097502) | 2.52866975 |
| 115 | cholesterol efflux (GO:0033344) | 2.52776071 |
| 116 | aldehyde catabolic process (GO:0046185) | 2.52112750 |
| 117 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.51783077 |
| 118 | alpha-linolenic acid metabolic process (GO:0036109) | 2.51260644 |
| 119 | regulation of timing of cell differentiation (GO:0048505) | 2.51092119 |
| 120 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.50512016 |
| 121 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.50057628 |
| 122 | fibrinolysis (GO:0042730) | 2.47863339 |
| 123 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.47495585 |
| 124 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.47495585 |
| 125 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.47495585 |
| 126 | glucuronate metabolic process (GO:0019585) | 2.46593759 |
| 127 | uronic acid metabolic process (GO:0006063) | 2.46593759 |
| 128 | ribonucleoprotein complex disassembly (GO:0032988) | 2.46502069 |
| 129 | amino acid import (GO:0043090) | 2.46241911 |
| 130 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.46193049 |
| 131 | cysteine metabolic process (GO:0006534) | 2.45651459 |
| 132 | nitrogen cycle metabolic process (GO:0071941) | 2.45569674 |
| 133 | intraciliary transport (GO:0042073) | 2.45251013 |
| 134 | regulation of complement activation (GO:0030449) | 2.45085651 |
| 135 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.45074849 |
| 136 | termination of RNA polymerase III transcription (GO:0006386) | 2.45074849 |
| 137 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.43801461 |
| 138 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.43801461 |
| 139 | synapsis (GO:0007129) | 2.43513209 |
| 140 | activated T cell proliferation (GO:0050798) | 2.43305282 |
| 141 | neuron remodeling (GO:0016322) | 2.43253756 |
| 142 | peripheral nervous system axon ensheathment (GO:0032292) | 2.43083036 |
| 143 | myelination in peripheral nervous system (GO:0022011) | 2.43083036 |
| 144 | terpenoid biosynthetic process (GO:0016114) | 2.42430418 |
| 145 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.42114452 |
| 146 | nucleobase catabolic process (GO:0046113) | 2.42048428 |
| 147 | eosinophil chemotaxis (GO:0048245) | 2.41502976 |
| 148 | steroid biosynthetic process (GO:0006694) | 2.41371522 |
| 149 | glutathione derivative biosynthetic process (GO:1901687) | 2.40537720 |
| 150 | glutathione derivative metabolic process (GO:1901685) | 2.40537720 |
| 151 | C-terminal protein lipidation (GO:0006501) | 2.40308243 |
| 152 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.40216613 |
| 153 | negative regulation of protein activation cascade (GO:2000258) | 2.39563218 |
| 154 | ubiquinone metabolic process (GO:0006743) | 2.39560015 |
| 155 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.38969812 |
| 156 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.38969812 |
| 157 | NADH dehydrogenase complex assembly (GO:0010257) | 2.38969812 |
| 158 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.38277036 |
| 159 | negative regulation of neurological system process (GO:0031645) | 2.37882112 |
| 160 | substantia nigra development (GO:0021762) | 2.37415024 |
| 161 | cellular glucuronidation (GO:0052695) | 2.37214793 |
| 162 | regulation of glucokinase activity (GO:0033131) | 2.36795408 |
| 163 | regulation of hexokinase activity (GO:1903299) | 2.36795408 |
| 164 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.36663147 |
| 165 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.36607711 |
| 166 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.36607711 |
| 167 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.34723607 |
| 168 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.34125518 |
| 169 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.33655856 |
| 170 | C-terminal protein amino acid modification (GO:0018410) | 2.32434263 |
| 171 | male meiosis I (GO:0007141) | 2.30371147 |
| 172 | thrombin receptor signaling pathway (GO:0070493) | 2.30024164 |
| 173 | regulation of translation in response to stress (GO:0043555) | 2.29801277 |
| 174 | cellular response to interferon-beta (GO:0035458) | 2.29049864 |
| 175 | cytochrome complex assembly (GO:0017004) | 2.28898924 |
| 176 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.27571968 |
| 177 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.27515187 |
| 178 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.27515187 |
| 179 | purine-containing compound salvage (GO:0043101) | 2.26743372 |
| 180 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.26511482 |
| 181 | GPI anchor metabolic process (GO:0006505) | 2.26131630 |
| 182 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.25942862 |
| 183 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.25476295 |
| 184 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.24552254 |
| 185 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.23373199 |
| 186 | negative regulation of interleukin-12 production (GO:0032695) | 2.21255405 |
| 187 | fucose metabolic process (GO:0006004) | 2.20622438 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.60199795 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.29733568 |
| 3 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.22771319 |
| 4 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.16712918 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.10702413 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.09601917 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.56628804 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.51589766 |
| 9 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.47442469 |
| 10 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.46620838 |
| 11 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.31533329 |
| 12 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.23634737 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.21397415 |
| 14 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.19484416 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.18610921 |
| 16 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.18168594 |
| 17 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.16958888 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.10662800 |
| 19 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.09117597 |
| 20 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.08715582 |
| 21 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.06867202 |
| 22 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.03580642 |
| 23 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.02053778 |
| 24 | EWS_26573619_Chip-Seq_HEK293_Human | 1.99129118 |
| 25 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.98301218 |
| 26 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.97644769 |
| 27 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.97616357 |
| 28 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.93356674 |
| 29 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.90249597 |
| 30 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.90211849 |
| 31 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.90006053 |
| 32 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.89957008 |
| 33 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.88507407 |
| 34 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.87555444 |
| 35 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.85788830 |
| 36 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.84102047 |
| 37 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.79688980 |
| 38 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.77369395 |
| 39 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.76847335 |
| 40 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.73751691 |
| 41 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.72573518 |
| 42 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.71934172 |
| 43 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.71102653 |
| 44 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.68198633 |
| 45 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.68198633 |
| 46 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.64524180 |
| 47 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.63332373 |
| 48 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.62131438 |
| 49 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.61626535 |
| 50 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.61244696 |
| 51 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.61045792 |
| 52 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.60591383 |
| 53 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.58846475 |
| 54 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.58606209 |
| 55 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.57806231 |
| 56 | VDR_22108803_ChIP-Seq_LS180_Human | 1.56907581 |
| 57 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.56676404 |
| 58 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.56039582 |
| 59 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.54946290 |
| 60 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.53672781 |
| 61 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.53051257 |
| 62 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.52300740 |
| 63 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.51377158 |
| 64 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.51080643 |
| 65 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.50368306 |
| 66 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.49934717 |
| 67 | FUS_26573619_Chip-Seq_HEK293_Human | 1.49174734 |
| 68 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.48960115 |
| 69 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.48832976 |
| 70 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.48791643 |
| 71 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.48692517 |
| 72 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.47780758 |
| 73 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.47390370 |
| 74 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.47279215 |
| 75 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.46166758 |
| 76 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.46141216 |
| 77 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.45387367 |
| 78 | * EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.44849893 |
| 79 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.44481279 |
| 80 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.43917073 |
| 81 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.43792921 |
| 82 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.43660536 |
| 83 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.43037433 |
| 84 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.42243204 |
| 85 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.40589329 |
| 86 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.38907935 |
| 87 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.38301856 |
| 88 | GATA3_26560356_Chip-Seq_TH2_Human | 1.37234455 |
| 89 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.37214519 |
| 90 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.37137277 |
| 91 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.35978948 |
| 92 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.35257205 |
| 93 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.34710966 |
| 94 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.33823982 |
| 95 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.33568069 |
| 96 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.33506675 |
| 97 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.32666879 |
| 98 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.32136344 |
| 99 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.31826700 |
| 100 | * HTT_18923047_ChIP-ChIP_STHdh_Human | 1.31387948 |
| 101 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.29845992 |
| 102 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.29578104 |
| 103 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.29370712 |
| 104 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.29334013 |
| 105 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.28629622 |
| 106 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.28435785 |
| 107 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.28260816 |
| 108 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.27627699 |
| 109 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.26334977 |
| 110 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.26334977 |
| 111 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.25398282 |
| 112 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.25296902 |
| 113 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.24395336 |
| 114 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.24249043 |
| 115 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.23858291 |
| 116 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.22956403 |
| 117 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.22956403 |
| 118 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.22168807 |
| 119 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.21162715 |
| 120 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.20160536 |
| 121 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.20013111 |
| 122 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.20005562 |
| 123 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.19671743 |
| 124 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18958541 |
| 125 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.18558906 |
| 126 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.17855184 |
| 127 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.17747622 |
| 128 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.17426980 |
| 129 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.16484742 |
| 130 | AR_20517297_ChIP-Seq_VCAP_Human | 1.15976002 |
| 131 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.14882633 |
| 132 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.11641878 |
| 133 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.11210315 |
| 134 | * POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.11035668 |
| 135 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.10606617 |
| 136 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.10437063 |
| 137 | KDM2B_26808549_Chip-Seq_REH_Human | 1.09197620 |
| 138 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.09167872 |
| 139 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.09162268 |
| 140 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.09162268 |
| 141 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.09085535 |
| 142 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.09085535 |
| 143 | AR_25329375_ChIP-Seq_VCAP_Human | 1.08546797 |
| 144 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.08391866 |
| 145 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07971286 |
| 146 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.07808391 |
| 147 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05866574 |
| 148 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.05866574 |
| 149 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.05634505 |
| 150 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.05618150 |
| 151 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.02325880 |
| 152 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.01801685 |
| 153 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.00975049 |
| 154 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00772470 |
| 155 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.99501489 |
| 156 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.98274286 |
| 157 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.97801892 |
| 158 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.95633597 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003136_yellow_coat_color | 4.90608594 |
| 2 | MP0004381_abnormal_hair_follicle | 3.76792547 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.60176314 |
| 4 | MP0005409_darkened_coat_color | 3.53347196 |
| 5 | MP0005360_urolithiasis | 3.16586043 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.07566980 |
| 7 | MP0003880_abnormal_central_pattern | 2.96239717 |
| 8 | MP0003195_calcinosis | 2.92786991 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 2.67905460 |
| 10 | MP0001188_hyperpigmentation | 2.64798470 |
| 11 | MP0005084_abnormal_gallbladder_morpholo | 2.59609468 |
| 12 | MP0000920_abnormal_myelination | 2.57905003 |
| 13 | MP0005365_abnormal_bile_salt | 2.55529766 |
| 14 | MP0002837_dystrophic_cardiac_calcinosis | 2.49977709 |
| 15 | MP0000566_synostosis | 2.39447983 |
| 16 | MP0008789_abnormal_olfactory_epithelium | 2.30279262 |
| 17 | MP0008877_abnormal_DNA_methylation | 2.29823200 |
| 18 | MP0006054_spinal_hemorrhage | 2.29629905 |
| 19 | MP0009785_altered_susceptibility_to | 2.26695431 |
| 20 | MP0003690_abnormal_glial_cell | 2.25209774 |
| 21 | MP0006082_CNS_inflammation | 2.22483369 |
| 22 | MP0001835_abnormal_antigen_presentation | 2.19985312 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 2.16864976 |
| 24 | MP0005171_absent_coat_pigmentation | 2.13160819 |
| 25 | MP0009379_abnormal_foot_pigmentation | 2.12030300 |
| 26 | MP0005671_abnormal_response_to | 2.04328782 |
| 27 | MP0000569_abnormal_digit_pigmentation | 2.04209289 |
| 28 | MP0005167_abnormal_blood-brain_barrier | 1.94889693 |
| 29 | MP0004742_abnormal_vestibular_system | 1.93417588 |
| 30 | MP0001486_abnormal_startle_reflex | 1.85333862 |
| 31 | MP0008058_abnormal_DNA_repair | 1.85298235 |
| 32 | MP0005451_abnormal_body_composition | 1.83252000 |
| 33 | MP0002736_abnormal_nociception_after | 1.78540815 |
| 34 | MP0004142_abnormal_muscle_tone | 1.78448579 |
| 35 | MP0005551_abnormal_eye_electrophysiolog | 1.77788554 |
| 36 | MP0003186_abnormal_redox_activity | 1.77608302 |
| 37 | MP0005394_taste/olfaction_phenotype | 1.68349014 |
| 38 | MP0005499_abnormal_olfactory_system | 1.68349014 |
| 39 | MP0004147_increased_porphyrin_level | 1.66735424 |
| 40 | MP0002653_abnormal_ependyma_morphology | 1.65670226 |
| 41 | MP0003806_abnormal_nucleotide_metabolis | 1.63897401 |
| 42 | MP0002138_abnormal_hepatobiliary_system | 1.61765920 |
| 43 | MP0003011_delayed_dark_adaptation | 1.55782377 |
| 44 | MP0000015_abnormal_ear_pigmentation | 1.55770607 |
| 45 | MP0002876_abnormal_thyroid_physiology | 1.55128641 |
| 46 | MP0001790_abnormal_immune_system | 1.54014985 |
| 47 | MP0005387_immune_system_phenotype | 1.54014985 |
| 48 | MP0006292_abnormal_olfactory_placode | 1.50562264 |
| 49 | MP0005379_endocrine/exocrine_gland_phen | 1.46994917 |
| 50 | MP0002272_abnormal_nervous_system | 1.45438395 |
| 51 | MP0003868_abnormal_feces_composition | 1.44569670 |
| 52 | MP0001905_abnormal_dopamine_level | 1.43465932 |
| 53 | MP0005000_abnormal_immune_tolerance | 1.37025902 |
| 54 | MP0003938_abnormal_ear_development | 1.36837771 |
| 55 | MP0003950_abnormal_plasma_membrane | 1.35709149 |
| 56 | MP0002064_seizures | 1.35303252 |
| 57 | MP0009745_abnormal_behavioral_response | 1.34875241 |
| 58 | MP0001529_abnormal_vocalization | 1.34347156 |
| 59 | MP0000685_abnormal_immune_system | 1.33421088 |
| 60 | MP0001661_extended_life_span | 1.30401322 |
| 61 | MP0009697_abnormal_copulation | 1.29654233 |
| 62 | MP0005646_abnormal_pituitary_gland | 1.29368144 |
| 63 | MP0001764_abnormal_homeostasis | 1.28158905 |
| 64 | MP0003252_abnormal_bile_duct | 1.28100967 |
| 65 | MP0000516_abnormal_urinary_system | 1.27040383 |
| 66 | MP0005367_renal/urinary_system_phenotyp | 1.27040383 |
| 67 | MP0001984_abnormal_olfaction | 1.26898843 |
| 68 | MP0001800_abnormal_humoral_immune | 1.26435650 |
| 69 | MP0000778_abnormal_nervous_system | 1.24168944 |
| 70 | MP0002332_abnormal_exercise_endurance | 1.23678047 |
| 71 | MP0001845_abnormal_inflammatory_respons | 1.22177275 |
| 72 | MP0006276_abnormal_autonomic_nervous | 1.21066494 |
| 73 | MP0002723_abnormal_immune_serum | 1.20802581 |
| 74 | MP0003303_peritoneal_inflammation | 1.20387025 |
| 75 | MP0005423_abnormal_somatic_nervous | 1.20315082 |
| 76 | MP0002452_abnormal_antigen_presenting | 1.20064315 |
| 77 | MP0000462_abnormal_digestive_system | 1.19372177 |
| 78 | MP0005332_abnormal_amino_acid | 1.17768810 |
| 79 | MP0001986_abnormal_taste_sensitivity | 1.17509804 |
| 80 | MP0001666_abnormal_nutrient_absorption | 1.15485602 |
| 81 | MP0010329_abnormal_lipoprotein_level | 1.14919178 |
| 82 | MP0006036_abnormal_mitochondrial_physio | 1.14807372 |
| 83 | MP0005408_hypopigmentation | 1.13333297 |
| 84 | MP0005025_abnormal_response_to | 1.11700530 |
| 85 | MP0008872_abnormal_physiological_respon | 1.10924515 |
| 86 | MP0001485_abnormal_pinna_reflex | 1.10474686 |
| 87 | MP0002102_abnormal_ear_morphology | 1.10172662 |
| 88 | MP0001968_abnormal_touch/_nociception | 1.07513319 |
| 89 | MP0000026_abnormal_inner_ear | 1.07305304 |
| 90 | MP0001324_abnormal_eye_pigmentation | 1.07145836 |
| 91 | MP0005647_abnormal_sex_gland | 1.06513286 |
| 92 | MP0002229_neurodegeneration | 1.06099243 |
| 93 | MP0001963_abnormal_hearing_physiology | 1.05824683 |
| 94 | MP0002095_abnormal_skin_pigmentation | 1.05767228 |
| 95 | MP0006035_abnormal_mitochondrial_morpho | 1.04881744 |
| 96 | MP0000427_abnormal_hair_cycle | 1.04238609 |
| 97 | MP0002419_abnormal_innate_immunity | 1.03769868 |
| 98 | MP0003724_increased_susceptibility_to | 1.03737937 |
| 99 | MP0002067_abnormal_sensory_capabilities | 1.03634474 |
| 100 | MP0010386_abnormal_urinary_bladder | 1.02960859 |
| 101 | MP0005310_abnormal_salivary_gland | 1.02915408 |
| 102 | MP0003172_abnormal_lysosome_physiology | 1.02716182 |
| 103 | MP0004270_analgesia | 1.01629471 |
| 104 | MP0001819_abnormal_immune_cell | 1.00219156 |
| 105 | MP0005253_abnormal_eye_physiology | 0.99488205 |
| 106 | MP0002420_abnormal_adaptive_immunity | 0.98932263 |
| 107 | MP0002118_abnormal_lipid_homeostasis | 0.97983706 |
| 108 | MP0002822_catalepsy | 0.97263793 |
| 109 | MP0001346_abnormal_lacrimal_gland | 0.97083563 |
| 110 | MP0002572_abnormal_emotion/affect_behav | 0.96214138 |
| 111 | MP0000631_abnormal_neuroendocrine_gland | 0.95305533 |
| 112 | MP0002752_abnormal_somatic_nervous | 0.95257221 |
| 113 | MP0005195_abnormal_posterior_eye | 0.94885650 |
| 114 | MP0002254_reproductive_system_inflammat | 0.93696829 |
| 115 | MP0003634_abnormal_glial_cell | 0.93691590 |
| 116 | MP0009046_muscle_twitch | 0.92210342 |
| 117 | MP0001440_abnormal_grooming_behavior | 0.92078402 |
| 118 | MP0000647_abnormal_sebaceous_gland | 0.91971439 |
| 119 | MP0004885_abnormal_endolymph | 0.90780510 |
| 120 | MP0004019_abnormal_vitamin_homeostasis | 0.90059556 |
| 121 | MP0005464_abnormal_platelet_physiology | 0.90002309 |
| 122 | MP0002277_abnormal_respiratory_mucosa | 0.86955122 |
| 123 | MP0002638_abnormal_pupillary_reflex | 0.86007695 |
| 124 | MP0002909_abnormal_adrenal_gland | 0.84896996 |
| 125 | MP0009765_abnormal_xenobiotic_induced | 0.84580474 |
| 126 | MP0008469_abnormal_protein_level | 0.84287473 |
| 127 | MP0002751_abnormal_autonomic_nervous | 0.84285084 |
| 128 | MP0005410_abnormal_fertilization | 0.84024905 |
| 129 | MP0010155_abnormal_intestine_physiology | 0.83978932 |
| 130 | MP0003787_abnormal_imprinting | 0.82957032 |
| 131 | MP0000579_abnormal_nail_morphology | 0.82643988 |
| 132 | MP0003635_abnormal_synaptic_transmissio | 0.82021644 |
| 133 | MP0004215_abnormal_myocardial_fiber | 0.81885073 |
| 134 | MP0003718_maternal_effect | 0.80960783 |
| 135 | MP0001177_atelectasis | 0.80553618 |
| 136 | MP0000689_abnormal_spleen_morphology | 0.80505555 |
| 137 | MP0009764_decreased_sensitivity_to | 0.80082114 |
| 138 | MP0001853_heart_inflammation | 0.79926559 |
| 139 | MP0002090_abnormal_vision | 0.79555467 |
| 140 | MP0000383_abnormal_hair_follicle | 0.79548035 |
| 141 | MP0000371_diluted_coat_color | 0.79510572 |
| 142 | MP0006072_abnormal_retinal_apoptosis | 0.79154673 |
| 143 | MP0003937_abnormal_limbs/digits/tail_de | 0.77851405 |
| 144 | MP0001502_abnormal_circadian_rhythm | 0.77172461 |
| 145 | MP0003436_decreased_susceptibility_to | 0.77121796 |
| 146 | MP0005083_abnormal_biliary_tract | 0.76459786 |
| 147 | MP0003632_abnormal_nervous_system | 0.76251608 |
| 148 | MP0000613_abnormal_salivary_gland | 0.75797118 |
| 149 | MP0002882_abnormal_neuron_morphology | 0.75638733 |
| 150 | MP0000358_abnormal_cell_content/ | 0.75281104 |
| 151 | MP0002405_respiratory_system_inflammati | 0.73788997 |
| 152 | MP0009384_cardiac_valve_regurgitation | 0.73520490 |
| 153 | MP0009250_abnormal_appendicular_skeleto | 0.73349710 |
| 154 | MP0002938_white_spotting | 0.73323520 |
| 155 | MP0002557_abnormal_social/conspecific_i | 0.72101563 |
| 156 | MP0002734_abnormal_mechanical_nocicepti | 0.71763060 |
| 157 | MP0003121_genomic_imprinting | 0.71596063 |
| 158 | MP0004883_abnormal_blood_vessel | 0.71522727 |
| 159 | MP0004133_heterotaxia | 0.71202665 |
| 160 | MP0002928_abnormal_bile_duct | 0.71117241 |
| 161 | MP0002735_abnormal_chemical_nociception | 0.70360658 |
| 162 | MP0001919_abnormal_reproductive_system | 0.69710077 |
| 163 | MP0000372_irregular_coat_pigmentation | 0.68971688 |
| 164 | MP0000762_abnormal_tongue_morphology | 0.68258406 |
| 165 | MP0005075_abnormal_melanosome_morpholog | 0.68176873 |
| 166 | MP0005645_abnormal_hypothalamus_physiol | 0.67930337 |
| 167 | MP0008260_abnormal_autophagy | 0.66958075 |
| 168 | MP0002163_abnormal_gland_morphology | 0.64863257 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged partial thromboplastin time (HP:0003645) | 4.49868152 |
| 2 | Stomatitis (HP:0010280) | 4.37910844 |
| 3 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.08717014 |
| 4 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.08717014 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 4.03626416 |
| 6 | Pancreatic cysts (HP:0001737) | 3.70620075 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.46438083 |
| 8 | Pancreatic fibrosis (HP:0100732) | 3.41930730 |
| 9 | Abnormality of incisor morphology (HP:0011063) | 3.37782689 |
| 10 | Abnormality of the axillary hair (HP:0100134) | 3.37197712 |
| 11 | Abnormality of secondary sexual hair (HP:0009888) | 3.37197712 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 3.24916666 |
| 13 | Parakeratosis (HP:0001036) | 3.15768688 |
| 14 | True hermaphroditism (HP:0010459) | 3.06765148 |
| 15 | Abnormality of midbrain morphology (HP:0002418) | 3.00153340 |
| 16 | Molar tooth sign on MRI (HP:0002419) | 3.00153340 |
| 17 | Conjugated hyperbilirubinemia (HP:0002908) | 2.97578272 |
| 18 | Nephronophthisis (HP:0000090) | 2.95679717 |
| 19 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.94471962 |
| 20 | Joint hemorrhage (HP:0005261) | 2.91806443 |
| 21 | Abnormality of the corticospinal tract (HP:0002492) | 2.90740100 |
| 22 | Abnormality of the renal cortex (HP:0011035) | 2.88503824 |
| 23 | Increased CSF lactate (HP:0002490) | 2.81214741 |
| 24 | Neurofibrillary tangles (HP:0002185) | 2.79998651 |
| 25 | Renal cortical cysts (HP:0000803) | 2.73933785 |
| 26 | Sensory axonal neuropathy (HP:0003390) | 2.73736956 |
| 27 | Hypobetalipoproteinemia (HP:0003563) | 2.73491505 |
| 28 | Anomalous pulmonary venous return (HP:0010772) | 2.68391537 |
| 29 | Conical tooth (HP:0000698) | 2.63979996 |
| 30 | Type 2 muscle fiber atrophy (HP:0003554) | 2.59074593 |
| 31 | Deep venous thrombosis (HP:0002625) | 2.58738069 |
| 32 | Abnormality of macular pigmentation (HP:0008002) | 2.58577516 |
| 33 | Abnormality of the renal medulla (HP:0100957) | 2.57150419 |
| 34 | Medial flaring of the eyebrow (HP:0010747) | 2.56409772 |
| 35 | Abnormality of methionine metabolism (HP:0010901) | 2.53788054 |
| 36 | Renal Fanconi syndrome (HP:0001994) | 2.52584095 |
| 37 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.51148241 |
| 38 | Septo-optic dysplasia (HP:0100842) | 2.50866522 |
| 39 | Xanthomatosis (HP:0000991) | 2.49081460 |
| 40 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.48154482 |
| 41 | Absent/shortened dynein arms (HP:0200106) | 2.48154482 |
| 42 | Optic disc pallor (HP:0000543) | 2.47182436 |
| 43 | Complement deficiency (HP:0004431) | 2.46525917 |
| 44 | Abolished electroretinogram (ERG) (HP:0000550) | 2.45651029 |
| 45 | Decreased central vision (HP:0007663) | 2.45008998 |
| 46 | Hypophosphatemic rickets (HP:0004912) | 2.44790994 |
| 47 | Hepatocellular necrosis (HP:0001404) | 2.43364733 |
| 48 | Humeroradial synostosis (HP:0003041) | 2.43108574 |
| 49 | Synostosis involving the elbow (HP:0003938) | 2.43108574 |
| 50 | Hepatic necrosis (HP:0002605) | 2.42248161 |
| 51 | Hyperglycinemia (HP:0002154) | 2.37235483 |
| 52 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.36315350 |
| 53 | Abnormality of the pulmonary veins (HP:0011718) | 2.34739538 |
| 54 | Fat malabsorption (HP:0002630) | 2.34643754 |
| 55 | White forelock (HP:0002211) | 2.31281537 |
| 56 | Patchy hypopigmentation of hair (HP:0011365) | 2.30687539 |
| 57 | Polyphagia (HP:0002591) | 2.30519570 |
| 58 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.30197772 |
| 59 | 3-Methylglutaconic aciduria (HP:0003535) | 2.29079337 |
| 60 | Fair hair (HP:0002286) | 2.28270828 |
| 61 | Methylmalonic aciduria (HP:0012120) | 2.27714428 |
| 62 | Amyotrophic lateral sclerosis (HP:0007354) | 2.27499726 |
| 63 | Acute encephalopathy (HP:0006846) | 2.26297572 |
| 64 | Acute necrotizing encephalopathy (HP:0006965) | 2.25553392 |
| 65 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.23875639 |
| 66 | Albinism (HP:0001022) | 2.22895856 |
| 67 | IgG deficiency (HP:0004315) | 2.21221078 |
| 68 | Abnormal protein glycosylation (HP:0012346) | 2.21030891 |
| 69 | Abnormal glycosylation (HP:0012345) | 2.21030891 |
| 70 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.21030891 |
| 71 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.21030891 |
| 72 | Absent septum pellucidum (HP:0001331) | 2.20633336 |
| 73 | Cupped ear (HP:0000378) | 2.19052070 |
| 74 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.17765841 |
| 75 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.17765841 |
| 76 | Abnormality of glycolipid metabolism (HP:0010969) | 2.17765841 |
| 77 | Cerebral edema (HP:0002181) | 2.15721784 |
| 78 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.15601363 |
| 79 | Recurrent cutaneous fungal infections (HP:0011370) | 2.15601363 |
| 80 | Pendular nystagmus (HP:0012043) | 2.14643164 |
| 81 | Anencephaly (HP:0002323) | 2.14157481 |
| 82 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.13431467 |
| 83 | Abnormality of glycine metabolism (HP:0010895) | 2.13431467 |
| 84 | Scanning speech (HP:0002168) | 2.12229479 |
| 85 | Steatorrhea (HP:0002570) | 2.09872072 |
| 86 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.09162728 |
| 87 | Abnormality of the septum pellucidum (HP:0007375) | 2.07673781 |
| 88 | Progressive macrocephaly (HP:0004481) | 2.07237242 |
| 89 | Tubular atrophy (HP:0000092) | 2.04712003 |
| 90 | Generalized aminoaciduria (HP:0002909) | 2.04165360 |
| 91 | Split foot (HP:0001839) | 2.03941728 |
| 92 | Hypoplastic nipples (HP:0002557) | 2.02360220 |
| 93 | Erythroderma (HP:0001019) | 2.02064447 |
| 94 | Abnormality of the common coagulation pathway (HP:0010990) | 2.01992524 |
| 95 | Abnormal ciliary motility (HP:0012262) | 2.01094506 |
| 96 | Cutaneous melanoma (HP:0012056) | 1.99491754 |
| 97 | Abnormality of serum amino acid levels (HP:0003112) | 1.98670821 |
| 98 | Abnormal pupillary function (HP:0007686) | 1.98129539 |
| 99 | Increased serum lactate (HP:0002151) | 1.98091905 |
| 100 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.97665188 |
| 101 | Muscle fiber atrophy (HP:0100295) | 1.96447190 |
| 102 | Vacuolated lymphocytes (HP:0001922) | 1.96157051 |
| 103 | Congenital sensorineural hearing impairment (HP:0008527) | 1.96029882 |
| 104 | Bile duct proliferation (HP:0001408) | 1.95757899 |
| 105 | Abnormal biliary tract physiology (HP:0012439) | 1.95757899 |
| 106 | Congenital primary aphakia (HP:0007707) | 1.95366487 |
| 107 | Aplasia involving bones of the extremities (HP:0009825) | 1.95303745 |
| 108 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.95303745 |
| 109 | Aplasia of the phalanges of the hand (HP:0009802) | 1.95303745 |
| 110 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.94881288 |
| 111 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.94710356 |
| 112 | Nephrogenic diabetes insipidus (HP:0009806) | 1.93842602 |
| 113 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.93371305 |
| 114 | Increased hepatocellular lipid droplets (HP:0006565) | 1.92710102 |
| 115 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.92344120 |
| 116 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.92344120 |
| 117 | Congenital stationary night blindness (HP:0007642) | 1.91642175 |
| 118 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.91228646 |
| 119 | Leukodystrophy (HP:0002415) | 1.90514298 |
| 120 | Sclerocornea (HP:0000647) | 1.90359525 |
| 121 | Pachygyria (HP:0001302) | 1.89789524 |
| 122 | Hyperventilation (HP:0002883) | 1.89219725 |
| 123 | Gait imbalance (HP:0002141) | 1.88846374 |
| 124 | Cystic liver disease (HP:0006706) | 1.88740329 |
| 125 | Methylmalonic acidemia (HP:0002912) | 1.88442271 |
| 126 | Abnormality of the parathyroid morphology (HP:0011766) | 1.88065124 |
| 127 | Mitochondrial inheritance (HP:0001427) | 1.87543019 |
| 128 | Thyroiditis (HP:0100646) | 1.87118768 |
| 129 | Type II lissencephaly (HP:0007260) | 1.87055626 |
| 130 | Abnormal sex determination (HP:0012244) | 1.85955480 |
| 131 | Sex reversal (HP:0012245) | 1.85955480 |
| 132 | Alacrima (HP:0000522) | 1.85904521 |
| 133 | Lactic acidosis (HP:0003128) | 1.85673097 |
| 134 | Spastic paraparesis (HP:0002313) | 1.85613141 |
| 135 | Increased IgM level (HP:0003496) | 1.85429217 |
| 136 | Amyloidosis (HP:0011034) | 1.85151423 |
| 137 | Lissencephaly (HP:0001339) | 1.83884472 |
| 138 | Stomach cancer (HP:0012126) | 1.83556677 |
| 139 | Lipid accumulation in hepatocytes (HP:0006561) | 1.82574866 |
| 140 | Hypoproteinemia (HP:0003075) | 1.82208521 |
| 141 | Mutism (HP:0002300) | 1.82016991 |
| 142 | Hypothermia (HP:0002045) | 1.81869417 |
| 143 | Thick nail (HP:0001805) | 1.79737828 |
| 144 | Epidermoid cyst (HP:0200040) | 1.79702870 |
| 145 | Attenuation of retinal blood vessels (HP:0007843) | 1.79066544 |
| 146 | Disproportionate short-trunk short stature (HP:0003521) | 1.78802615 |
| 147 | Nausea (HP:0002018) | 1.78402875 |
| 148 | Optic nerve hypoplasia (HP:0000609) | 1.78236858 |
| 149 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.77117458 |
| 150 | Retrobulbar optic neuritis (HP:0100654) | 1.76952756 |
| 151 | Optic neuritis (HP:0100653) | 1.76952756 |
| 152 | Congenital hepatic fibrosis (HP:0002612) | 1.76817409 |
| 153 | Confusion (HP:0001289) | 1.76241359 |
| 154 | Exertional dyspnea (HP:0002875) | 1.76186478 |
| 155 | Chronic hepatic failure (HP:0100626) | 1.75524533 |
| 156 | Recurrent fungal infections (HP:0002841) | 1.75493270 |
| 157 | Prolonged neonatal jaundice (HP:0006579) | 1.75256414 |
| 158 | Peripheral hypomyelination (HP:0007182) | 1.75072174 |
| 159 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.74402671 |
| 160 | Blue irides (HP:0000635) | 1.74215513 |
| 161 | Chin dimple (HP:0010751) | 1.73931732 |
| 162 | Widely spaced teeth (HP:0000687) | 1.73799596 |
| 163 | Abnormality of B cell number (HP:0010975) | 1.73736071 |
| 164 | Bifid scrotum (HP:0000048) | 1.73454113 |
| 165 | Abnormality of urine glucose concentration (HP:0011016) | 1.73420613 |
| 166 | Glycosuria (HP:0003076) | 1.73420613 |
| 167 | Type I transferrin isoform profile (HP:0003642) | 1.72834103 |
| 168 | Partial agenesis of the corpus callosum (HP:0001338) | 1.72796899 |
| 169 | Abnormality of dental color (HP:0011073) | 1.71520980 |
| 170 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.71438024 |
| 171 | Abnormality of placental membranes (HP:0011409) | 1.70731660 |
| 172 | Amniotic constriction ring (HP:0009775) | 1.70731660 |
| 173 | Abnormality of renal resorption (HP:0011038) | 1.69855360 |
| 174 | Lethargy (HP:0001254) | 1.69019797 |
| 175 | Hyperglycinuria (HP:0003108) | 1.68113631 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 5.31578328 |
| 2 | TNIK | 5.28162394 |
| 3 | TRIM28 | 3.67743861 |
| 4 | STK39 | 3.50643711 |
| 5 | FRK | 3.28151346 |
| 6 | MAP4K2 | 3.26213813 |
| 7 | EIF2AK3 | 2.58062710 |
| 8 | ACVR1B | 2.44605419 |
| 9 | MKNK2 | 2.37089453 |
| 10 | PKN1 | 2.27979084 |
| 11 | OXSR1 | 2.26396598 |
| 12 | WNK3 | 2.03640788 |
| 13 | EPHB1 | 1.99289256 |
| 14 | PINK1 | 1.93644585 |
| 15 | PBK | 1.77090787 |
| 16 | SIK3 | 1.74684527 |
| 17 | IRAK1 | 1.73400690 |
| 18 | TLK1 | 1.72275746 |
| 19 | ERBB3 | 1.64369293 |
| 20 | MAP3K12 | 1.61919014 |
| 21 | NEK6 | 1.61187535 |
| 22 | IRAK2 | 1.60431156 |
| 23 | INSRR | 1.58674641 |
| 24 | TIE1 | 1.54902420 |
| 25 | BCR | 1.54027016 |
| 26 | MST4 | 1.53493067 |
| 27 | STK16 | 1.50723453 |
| 28 | MKNK1 | 1.47808096 |
| 29 | CLK1 | 1.46481920 |
| 30 | MAP2K7 | 1.38457809 |
| 31 | FES | 1.36304057 |
| 32 | EIF2AK1 | 1.35452583 |
| 33 | ADRBK2 | 1.32688230 |
| 34 | ERBB4 | 1.30865070 |
| 35 | FGR | 1.29139726 |
| 36 | IRAK4 | 1.27214912 |
| 37 | EPHA4 | 1.24739387 |
| 38 | MAPK15 | 1.23636987 |
| 39 | MAPK13 | 1.21476626 |
| 40 | MATK | 1.21025369 |
| 41 | IRAK3 | 1.20387699 |
| 42 | PHKG1 | 1.19403989 |
| 43 | PHKG2 | 1.19403989 |
| 44 | GRK1 | 1.17828112 |
| 45 | BMPR2 | 1.17277517 |
| 46 | WNK4 | 1.15537895 |
| 47 | GRK7 | 1.12421351 |
| 48 | NLK | 1.10710282 |
| 49 | CAMKK2 | 1.09953943 |
| 50 | FGFR2 | 1.07928123 |
| 51 | MAP3K3 | 1.06982879 |
| 52 | MUSK | 1.04989022 |
| 53 | PNCK | 1.04506860 |
| 54 | TGFBR1 | 1.01952815 |
| 55 | PIK3CG | 1.01606691 |
| 56 | DYRK3 | 1.01346333 |
| 57 | NEK1 | 1.00144682 |
| 58 | UHMK1 | 0.99415238 |
| 59 | DYRK2 | 0.97347671 |
| 60 | SGK494 | 0.94555556 |
| 61 | SGK223 | 0.94555556 |
| 62 | CAMK2A | 0.92529244 |
| 63 | PRKCE | 0.92112299 |
| 64 | CAMK2B | 0.90423839 |
| 65 | NUAK1 | 0.89925003 |
| 66 | FER | 0.85456499 |
| 67 | CSNK1G1 | 0.85132462 |
| 68 | PRPF4B | 0.84975551 |
| 69 | DYRK1A | 0.84070490 |
| 70 | PRKCQ | 0.82396941 |
| 71 | CAMK2G | 0.80764775 |
| 72 | CDK3 | 0.80543429 |
| 73 | SRPK1 | 0.80515540 |
| 74 | YES1 | 0.78320126 |
| 75 | CSNK1A1L | 0.77482399 |
| 76 | CAMK2D | 0.76857381 |
| 77 | MARK1 | 0.75829274 |
| 78 | BLK | 0.75007588 |
| 79 | MARK3 | 0.74765518 |
| 80 | MET | 0.73984389 |
| 81 | EIF2AK2 | 0.73963960 |
| 82 | BRD4 | 0.73259481 |
| 83 | CSNK1G3 | 0.72935341 |
| 84 | MAP2K4 | 0.72465563 |
| 85 | TEC | 0.70812314 |
| 86 | IKBKB | 0.68558153 |
| 87 | MAPKAPK5 | 0.68463134 |
| 88 | KSR1 | 0.67343108 |
| 89 | TAOK3 | 0.65509958 |
| 90 | WNK1 | 0.65040067 |
| 91 | PRKG1 | 0.63335787 |
| 92 | MAPKAPK3 | 0.62471126 |
| 93 | NTRK3 | 0.62443319 |
| 94 | MAP3K14 | 0.62161070 |
| 95 | MAP3K4 | 0.61251437 |
| 96 | PIK3CA | 0.59617477 |
| 97 | TNK2 | 0.59517829 |
| 98 | ROCK2 | 0.59297550 |
| 99 | GRK5 | 0.58024039 |
| 100 | JAK3 | 0.57034886 |
| 101 | TXK | 0.55807816 |
| 102 | LYN | 0.55188861 |
| 103 | ADRBK1 | 0.55060547 |
| 104 | MAP3K5 | 0.54795583 |
| 105 | PLK3 | 0.54504310 |
| 106 | KIT | 0.53865517 |
| 107 | ABL1 | 0.52574201 |
| 108 | BRSK2 | 0.52419879 |
| 109 | CSNK1G2 | 0.50438602 |
| 110 | PRKACA | 0.50256762 |
| 111 | EPHA3 | 0.46107757 |
| 112 | ABL2 | 0.45120488 |
| 113 | CSK | 0.44908021 |
| 114 | STK24 | 0.44878654 |
| 115 | PLK4 | 0.44780660 |
| 116 | NME1 | 0.44750988 |
| 117 | PRKCI | 0.44004439 |
| 118 | STK3 | 0.43974908 |
| 119 | TGFBR2 | 0.43559564 |
| 120 | CCNB1 | 0.42990842 |
| 121 | CDK19 | 0.41385967 |
| 122 | * EGFR | 0.40029845 |
| 123 | PRKCG | 0.39989628 |
| 124 | PTK2B | 0.39802513 |
| 125 | BMPR1B | 0.39568424 |
| 126 | ZAK | 0.39205275 |
| 127 | PRKAA2 | 0.38744755 |
| 128 | GSK3A | 0.38633520 |
| 129 | PAK3 | 0.38110171 |
| 130 | IKBKE | 0.37744628 |
| 131 | AKT3 | 0.36820832 |
| 132 | PLK2 | 0.36411379 |
| 133 | BCKDK | 0.36355821 |
| 134 | FYN | 0.36299664 |
| 135 | NTRK2 | 0.35321738 |
| 136 | TYRO3 | 0.34935888 |
| 137 | RPS6KA5 | 0.34262897 |
| 138 | NTRK1 | 0.34153276 |
| 139 | PDK2 | 0.33620070 |
| 140 | LIMK1 | 0.33379664 |
| 141 | CDK5 | 0.33261830 |
| 142 | CSNK1A1 | 0.33217507 |
| 143 | PRKD2 | 0.33036443 |
| 144 | PIM2 | 0.32658039 |
| 145 | STK38L | 0.32475536 |
| 146 | LCK | 0.32260563 |
| 147 | TYK2 | 0.31745343 |
| 148 | SYK | 0.31646008 |
| 149 | MYLK | 0.31523424 |
| 150 | CSNK2A1 | 0.30230751 |
| 151 | CDK8 | 0.29712194 |
| 152 | VRK1 | 0.29200409 |
| 153 | DAPK1 | 0.29195523 |
| 154 | IGF1R | 0.28059489 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.56123670 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.32486954 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.28892651 |
| 4 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.15126953 |
| 5 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.71805750 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.68734947 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.68109659 |
| 8 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.61570198 |
| 9 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.49311685 |
| 10 | Asthma_Homo sapiens_hsa05310 | 2.44148039 |
| 11 | Histidine metabolism_Homo sapiens_hsa00340 | 2.36911606 |
| 12 | Basal transcription factors_Homo sapiens_hsa03022 | 2.32234839 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 2.27818956 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.25478325 |
| 15 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.20754578 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.13739960 |
| 17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.12613020 |
| 18 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.12204208 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.11931949 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 2.08401124 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.00211713 |
| 22 | RNA polymerase_Homo sapiens_hsa03020 | 1.95982134 |
| 23 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.95155283 |
| 24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.93381789 |
| 25 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.91450085 |
| 26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.88218317 |
| 27 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.83484962 |
| 28 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.82088168 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.81205037 |
| 30 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.81172666 |
| 31 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.73145257 |
| 32 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.71854323 |
| 33 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.71053298 |
| 34 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.67134208 |
| 35 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.66629018 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.55483637 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.52245139 |
| 38 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.49594794 |
| 39 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.44298908 |
| 40 | Protein export_Homo sapiens_hsa03060 | 1.43201995 |
| 41 | Phototransduction_Homo sapiens_hsa04744 | 1.43072140 |
| 42 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.42694231 |
| 43 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.35995684 |
| 44 | Legionellosis_Homo sapiens_hsa05134 | 1.35177824 |
| 45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.34457345 |
| 46 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.31121468 |
| 47 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.27417634 |
| 48 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.27172538 |
| 49 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.18302964 |
| 50 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.17808840 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 1.17128913 |
| 52 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.14635116 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 1.12966560 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.12472057 |
| 55 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.12350264 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.10878276 |
| 57 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.10814532 |
| 58 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.09372153 |
| 59 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.08870805 |
| 60 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.08186189 |
| 61 | Nicotine addiction_Homo sapiens_hsa05033 | 1.07558463 |
| 62 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.06993627 |
| 63 | Lysosome_Homo sapiens_hsa04142 | 1.06659760 |
| 64 | Homologous recombination_Homo sapiens_hsa03440 | 1.05112451 |
| 65 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.04893859 |
| 66 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.04727334 |
| 67 | Alzheimers disease_Homo sapiens_hsa05010 | 1.03432739 |
| 68 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.00594483 |
| 69 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.00040910 |
| 70 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.98420045 |
| 71 | Parkinsons disease_Homo sapiens_hsa05012 | 0.98161607 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.97240183 |
| 73 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.96351438 |
| 74 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.94627360 |
| 75 | RNA degradation_Homo sapiens_hsa03018 | 0.94584084 |
| 76 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.93485688 |
| 77 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.91150788 |
| 78 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.90386109 |
| 79 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.90223170 |
| 80 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.89780975 |
| 81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.89648843 |
| 82 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.88494830 |
| 83 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.83633787 |
| 84 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.83021497 |
| 85 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.81607782 |
| 86 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.80047684 |
| 87 | GABAergic synapse_Homo sapiens_hsa04727 | 0.79137652 |
| 88 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.79115787 |
| 89 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.78713435 |
| 90 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.77247525 |
| 91 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.77064494 |
| 92 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.76080573 |
| 93 | Tuberculosis_Homo sapiens_hsa05152 | 0.74751304 |
| 94 | Axon guidance_Homo sapiens_hsa04360 | 0.72420710 |
| 95 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.71563753 |
| 96 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.69096207 |
| 97 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.68972097 |
| 98 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.68855791 |
| 99 | Bile secretion_Homo sapiens_hsa04976 | 0.67959936 |
| 100 | Phagosome_Homo sapiens_hsa04145 | 0.67818889 |
| 101 | Metabolic pathways_Homo sapiens_hsa01100 | 0.66713674 |
| 102 | Morphine addiction_Homo sapiens_hsa05032 | 0.59754335 |
| 103 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.59528423 |
| 104 | Huntingtons disease_Homo sapiens_hsa05016 | 0.58224414 |
| 105 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.57827164 |
| 106 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.56649835 |
| 107 | Leishmaniasis_Homo sapiens_hsa05140 | 0.54029833 |
| 108 | RNA transport_Homo sapiens_hsa03013 | 0.53863292 |
| 109 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53595060 |
| 110 | Salmonella infection_Homo sapiens_hsa05132 | 0.53590223 |
| 111 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.53441803 |
| 112 | Pertussis_Homo sapiens_hsa05133 | 0.53152032 |
| 113 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.52816046 |
| 114 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.52505000 |
| 115 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.51108183 |
| 116 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.50836097 |
| 117 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.49720543 |
| 118 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.48778972 |
| 119 | Measles_Homo sapiens_hsa05162 | 0.46585460 |
| 120 | Shigellosis_Homo sapiens_hsa05131 | 0.45142059 |
| 121 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44914203 |
| 122 | Purine metabolism_Homo sapiens_hsa00230 | 0.43853153 |
| 123 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.43598080 |
| 124 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.41687534 |
| 125 | Sulfur relay system_Homo sapiens_hsa04122 | 0.41118749 |
| 126 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.40958907 |
| 127 | Taste transduction_Homo sapiens_hsa04742 | 0.39196666 |
| 128 | Long-term depression_Homo sapiens_hsa04730 | 0.37974161 |
| 129 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36379713 |
| 130 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.36054056 |
| 131 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.30772162 |
| 132 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.30104446 |
| 133 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.30066883 |
| 134 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.29549051 |
| 135 | Prion diseases_Homo sapiens_hsa05020 | 0.27942425 |
| 136 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.24421577 |
| 137 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.23534732 |
| 138 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.22052656 |
| 139 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.20248779 |
| 140 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.18759413 |
| 141 | Malaria_Homo sapiens_hsa05144 | 0.18722412 |
| 142 | Other glycan degradation_Homo sapiens_hsa00511 | 0.16547473 |
| 143 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.15464619 |
| 144 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.14923247 |
| 145 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.12592194 |
| 146 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.12588375 |

